Protheragen at JPM 2026 | Strengthening Global Pharmaceutical Supply and Chemical Asset Transactions

Protheragen, a leading international active pharmaceutical ingredients (API) supplier and contract integrated chemical R&D solutions provider, recently announced its participation in the JP Morgan Healthcare Conference 2026 (JPM 2026). Protheragen has leveraged its robust chemical manufacturing legacy of more than 10 years combined with transaction brokerage experience to cater to the needs of the chemical industry worldwide.

About the JP Morgan Healthcare Conference

The JP Morgan Healthcare Conference (JPM) is one of the largest and most attended investment and matchmaking events in the industry. Renowned for setting the pulse of the industry globally, JPM attendees include prominent pharma players, investors, and leading technical services companies. These industry gatherings cater for high-quality meetings, top-tier assets, strategic deals, investment opportunities, and exploring new trends.

Protheragen and JPM 2026

At JPM 2026, Protheragen leveraged its two core strengths to showcase its full-stack capabilities to partners across the globe.

Reliable Pharmaceutical & Chemical Supply

As a trusted supplier, Protheragen leverages its industrial foundation to enhance R&D efficiency.

cGMP production

State-of-the-art manufacturing bases provide a seamless transition from research to large-scale production.

Diverse product portfolio

A robust supply of APIs (including Anti-tumor, NSAIDs, and more), pharmaceutical excipients, and advanced delivery technologies like lyophilized flash release formulations and microneedles.

AI-powered synthesis

Utilize AI-powered drug discovery and design services to optimize small molecule development and provide cost-effective chemical solutions.

Premium Transaction Support

We focused on meaningful 1-on-1 meetings with industry giants like Sanofi, AstraZeneca, and Eli Lilly during the 4-day event. Protheragen specializes in supporting the flow of premier pharmaceutical assets.

Outside of JPM, our team also participated in BIO Partnering @ JPM Week, SAPA Investment Forum, and several targeted satellite meetings. We continued to meet with contacts throughout the week allowing us to broaden our international reach while sensing the market. We pride ourselves on connecting high-quality assets with investors from around the world.

Empowering the Global Industry

Through our participation in JPM 2026, we highlight our commitment to breaking down barriers in R&D. We offer our partners zero-cost matchmaking services and flexible collaboration models to help them allocate resources efficiently and fast-track the commercialization of pharma solutions.

Protheragen is committed to creating a frictionless ecosystem for players in the pharmaceutical and chemical industry. We have the power of the supply chain at our disposal, as well as deal-making experts to ensure you can compete globally with total confidence.

If you are looking for quality products supplier or need help expediting an international transaction, please reach out to us today to see how we can facilitate your project success.